---
$id: https://graph.org.ai/products/commodity/51281664
$type: Product
source: UNSPSC
code: "51281664"
title: "Ribostamycin sulfate"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ribostamycin sulfate

**UNSPSC Code**: 51281664
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic C17H34N4O10.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QFN1QU7PEN, chemically known as o-2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(.beta-d-ribofuranosyl-(1->5))-2-deoxy-d-streptamine sulfate, but more generally known as ribostamycin sulfate, which bears US NIH Compound Identifier 5702279. European Medicines Agency schedules in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04244MIG. Most nations, for tariff and trade purposes, schedule ribostamycin sulfate under HS 29419000 and SITC 54139. As of Q4 2014, RIBOSTAMYCIN SULFATE remains US FDA's Preferred Term for this commodity. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O)N.OS(=O)(=O)O.

